Ortalox (Omeprazole)

Omeprazole, the active ingredient in Ortalox, is a proton pump inhibitor presented as an oral dosage form for oral use. It reduces gastric acid secretion and is used to manage acid‑related disorders such as gastro‑esophageal reflux disease, peptic ulcer disease and erosive esophagitis in adult patients.

GNH USA supplies Ortalox as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with a focus on quality assurance and regulatory compliance. Our distribution network ensures reliable delivery to diverse healthcare settings across multiple regions.

Omeprazole is a proton pump inhibitor used to treat conditions related to excess gastric acid. - Gastro‑esophageal reflux disease (GERD): provides symptomatic relief and promotes healing of esophageal irritation. - Peptic ulcer disease: facilitates ulcer healing by reducing acid exposure. - Erosive esophagitis: promotes mucosal healing and reduces further damage. - Helicobacter pylori eradication (in combination therapy): enhances eradication rates when combined with antibiotics. - Zollinger‑Ellison syndrome: reduces gastric acid hypersecretion.

Adverse reactions may occur with omeprazole therapy.

Common Side Effects: - Headache: mild headache reported in some patients. - Diarrhea: loose stools or increased frequency. - Nausea: feeling of queasiness. - Abdominal pain: mild stomach discomfort.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, or anaphylaxis. - Low magnesium levels: may cause muscle cramps or irregular heartbeat. - Clostridioides difficile infection: persistent diarrhea with abdominal pain.

Use omeprazole with appropriate clinical caution. - Assess renal function: adjust use in severe renal impairment. - Monitor magnesium: long‑term therapy may deplete magnesium levels. - Evaluate liver disease: use cautiously in hepatic impairment. - Review concomitant medications: potential for drug interactions. - Pregnancy and lactation: safety not established; use only if benefit outweighs risk. - Store at ambient temperature: keep in original container, protect from moisture and light.

Omeprazole can affect the pharmacokinetics of several drugs.

Major Interactions (Avoid): - Ketoconazole: reduced absorption of ketoconazole. - Atazanavir: decreased antiviral levels. - Clopidogrel: reduced activation of clopidogrel. - Warfarin: increased INR and bleeding risk.

Moderate Interactions (Monitor Closely): - Digoxin: may increase serum digoxin concentrations. - Methotrexate: increased risk of toxicity. - HIV protease inhibitors: altered drug concentrations requiring dose adjustment.